Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Hubbell (HUBB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Hubbell — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.97 (market cap $4.59B), while Hubbell trades at $477.13 (market cap $25.12B). The key difference: Hubbell is far larger — about 5.5× Definium Therapeutics Inc. Common Shares's market cap, and Hubbell pays a 1.19% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Hubbell for 3 Days on average.
| DFTX | HUBB | |
|---|---|---|
Market Cap | $4.59B | $25.12B |
Volume | 2,103,937 | 784,557 |
Sector | Health | Industrials |
52-Week High | $48.45 | $557.85 |
52-Week Low | $10.68 | $407.36 |
Typical Hold Time | 0 Days | 3 Days |
Enterprise Value | $3.55B | $30.28B |
Dividend Yield | — | 1.19% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Hubbell
Hubbell manufactures electrical and utility products used in transmission, distribution, and electrical infrastructure. Its portfolio includes components and systems for utilities, data centers, industrial facilities, and buildings.
Read more on HUBB →
